Cargando…
Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
Many women experience bothersome vasomotor and vaginal symptoms during the menopausal transition. Decreasing levels of estrogens during menopause are also associated with reduced bone density and an increased risk of osteoporosis. Combined estrogen/progestin therapy (hormone therapy) effectively tre...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325004/ https://www.ncbi.nlm.nih.gov/pubmed/22505832 http://dx.doi.org/10.2147/IJWH.S29346 |